European Journal of Surgical Oncology
Volume 36, Issue 2 , Pages 148-154 , February 2010

Health-related quality of life and survival in the 2years after surgery for gastric cancer

  • K. Avery

      Affiliations

    • Department of Social Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Clifton, Bristol BS8 2PS, UK
    • ,
  • R. Hughes

      Affiliations

    • Department of Social Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Clifton, Bristol BS8 2PS, UK
    • ,
  • A. McNair

      Affiliations

    • Department of Social Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Clifton, Bristol BS8 2PS, UK
    • University Hospitals Bristol NHS Foundation Trust, Bristol BS2 8HW, UK
    • ,
  • D. Alderson

      Affiliations

    • Clinical Sciences at South Bristol, Bristol Royal Infirmary, Bristol BS2 8HW, UK
    • ,
  • P. Barham

      Affiliations

    • University Hospitals Bristol NHS Foundation Trust, Bristol BS2 8HW, UK
    • ,
  • J. Blazeby

      Affiliations

    • Department of Social Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Clifton, Bristol BS8 2PS, UK
    • University Hospitals Bristol NHS Foundation Trust, Bristol BS2 8HW, UK
    • Clinical Sciences at South Bristol, Bristol Royal Infirmary, Bristol BS2 8HW, UK
    • Corresponding Author InformationCorresponding author. Department of Social Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Clifton, Bristol BS8 2PS, UK. Tel.: +44 117 928 7231; fax: +44 117 925 2736.

,Accepted 21 September 2009.

References 

  1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18–29
  2. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20
  3. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–730
  4. Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–1820
  5. Blazeby JM, Avery K, Sprangers M, Pikhart H, Fayers P, Donovan J. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol. 2006;24:3178–3186
  6. Medical Defence Union . Consent to treatment. Available from URL http://www.the-mdu.com/associatedArticles/consent.pdf[accessed May 30, 2008]
  7. General Medical Council . Seeking patients’ consent: the ethical considerations. Available from URL http://www.gmc-uk.org/guidance/current/library/consent.asp[accessed May 30, 2008]
  8. Aaronson N, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376
  9. Vickery C, Blazeby J, Conroy T, et al. Development of an EORTC specific quality of life module for use in patients with gastric cancer. Eur J Cancer. 2001;37:966–971
  10. Blazeby JM, Conroy T, Bottomley A, et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer. 2004;40:2260–2268
  11. Fayers P, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. EORTC QLQ-C30 Scoring Manual. 3rd, 0–86; 2001.
  12. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality of life scores. J Clin Oncol. 1998;16:139–144
  13. Blazeby JM, Sanford E, Falk SJ, Alderson D, Donovan JL. Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma. Cancer. 2005;1791–1799
  14. Reynolds JV, McLaughlin R, Moore J, Rowley S, Ravi N, Byrne PJ. Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Br J Surg. 2006;93:1084–1090
  15. Cunningham D. STO3 a randomised phase II/III trial of peri-operative chemotherapy with or without bevacizumab in operable adenocarcinoma of the stomach and gastro-oesophageal junction. Medical Research Council Clinical Trial; 2008.
  16. Zieren HU, Zippel K, Zieren J, Muller JM. Quality of life after surgical treatment of gastric carcinoma. Eur J Surg. 1998;164:119–125
  17. Wu CW, Chiou JM, Ko FS, Lo SS, Chen JH, Lui WY, et al. Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial. Br J Cancer. 2008;98(1):54–59
  18. Blazeby JM, Conroy T, Bottomley A, Vickery C, Arraras J, Sezer O, et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer. 2004;40(15):2260–2268
  19. Rutten LJ, Arora NK, Bakos AD, Aziz N, Rowland J. Information needs and sources of information among cancer patients: a systematic review of research. Patient Educ Couns. 1980–2003;2005(57):250–261
  20. Skene L, Smallwood R. Informed consent: lessons from Australia. BMJ. 2002;324:39–41
  21. General Medical Council. Consent: patients and doctors making decisions together; 2008.
  22. Faden RR, Beauchamp TL, King NM. Understanding. A history and theory of informed consent. New York: Oxford University Press; 1986;
  23. Brundage M, Feldman-Stewart D, Leis A, et al. Communicating quality of life information to cancer patients: a study of six presentation formats. J Clin Oncol. 2005;23(28):6949–6956
  24. Sobin LH, Ch Wittekind. Oesophagus (ICD-O C15). In:  Sobin LH,  Ch Wittkind editor. TNM classification of malignant tumours. 6th ed. New York: A John Wiley & Sons, Inc; 2002;p. 60–69
  25. Kim YW, Baik YH, Yun YH, et al. Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg. 2008;248(5):721–727

PII: S0748-7983(09)00469-7

doi: 10.1016/j.ejso.2009.09.008

European Journal of Surgical Oncology
Volume 36, Issue 2 , Pages 148-154 , February 2010

Article Tools

* Image Usage & Resolution